BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun J, Rajsbaum R, Yi M. Immune and non-immune responses to hepatitis C virus infection. World J Gastroenterol 2015; 21(38): 10739-10748 [PMID: 26478666 DOI: 10.3748/wjg.v21.i38.10739]
URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10739.htm
Number Citing Articles
1
Pratichi Singh, Febin Prabhu Dass J. A Biomolecular Network Driven Proteinic Interaction in HCV ClearanceCell Biochemistry and Biophysics 2018; 76(1-2): 161 doi: 10.1007/s12013-017-0837-y
2
Gesche Gerresheim, Jochen Bathke, Audrey Michel, Dmitri Andreev, Lyudmila Shalamova, Oliver Rossbach, Pan Hu, Dieter Glebe, Markus Fricke, Manja Marz, Alexander Goesmann, Stephen Kiniry, Pavel Baranov, Ivan Shatsky, Michael Niepmann. Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome ProfilingInternational Journal of Molecular Sciences 2019; 20(6): 1321 doi: 10.3390/ijms20061321
3
Hawa Vahed, Anshu Agrawal, Ruchi Srivastava, Swayam Prakash, Pierre-Gregoire A. Coulon, Soumyabrata Roy, Lbachir BenMohamed, Jae U. Jung. Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8 + T EM Cells Are Associated with Asymptomatic Herpes in Humans Journal of Virology 2019; 93(4) doi: 10.1128/JVI.01882-18
4
Qianqian Zhang, Yang Wang, Naicui Zhai, Hongxiao Song, Haijun Li, Yang Yang, Tianyang Li, Xiaolin Guo, Baorong Chi, Junqi Niu, Ian Nicholas Crispe, Lishan Su, Zhengkun Tu. HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathwayScientific Reports 2016; 6(1) doi: 10.1038/srep36160
5
Sina Alizadeh, Shiva Irani, Azam Bolhassani, Seyed Mehdi Sadat. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responsesImmunology Letters 2019; 212: 70 doi: 10.1016/j.imlet.2019.06.011
6
Ken Sato, Yuichi Yamazaki, Takeshi Kobayashi, Satoshi Takakusagi, Norio Horiguchi, Satoru Kakizaki, Masayasu Andou, Yoshihiro Matsuda, Toshio Uraoka, Hiroshi Ohnishi, Hiroaki Okamoto. Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literatureWorld Journal of Clinical Cases 2019; 7(9): 1043-1052 doi: 10.12998/wjcc.v7.i9.1043
7
Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer CellsCells 2019; 8(11): 1410 doi: 10.3390/cells8111410
8
D. V. Mishin, E. I. Isaeva, S. S. Grigorian, A. A. Balakina, A. V. Ilyichev, P. G. Deryabin, D. G. Maldov. The Mechanism of Suppression of Chronic Hepatitis C Infection by the Medicine StimforteBiology Bulletin 2020; 47(5): 448 doi: 10.1134/S1062359020050076
9
Marina Barriocanal, Puri Fortes. Long Non-coding RNAs in Hepatitis C Virus-Infected CellsFrontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01833
10
Miaoqing Zhang, Linli Li, Linzhuan Wu, Jingpu Zhang. Isarubrolone C Promotes Autophagic Degradation of Virus Proteins via Activating ATG10S in HepG2 CellsJournal of Natural Products 2022; 85(4): 1018 doi: 10.1021/acs.jnatprod.1c01161
11
Takashi Kida, Atsushi Umemura, Shunya Kaneshita, Risa Sagawa, Takuya Inoue, Shogo Toyama, Makoto Wada, Masataka Kohno, Ryo Oda, Tohru Inaba, Yoshito Itoh, Yutaka Kawahito. Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-seriesModern Rheumatology 2020; 30(6): 1009 doi: 10.1080/14397595.2019.1682787
12
Michael Niepmann, Gesche K. Gerresheim. Hepatitis C Virus Translation RegulationInternational Journal of Molecular Sciences 2020; 21(7): 2328 doi: 10.3390/ijms21072328
13
Lucrèce Y.J. Ahovègbé, Patrick E. Ogwang, Emanuel L. Peter, Andrew G. Mtewa, Félicien M. Kasali, Casim U. Tolo, Judith Gbenoudon, Anke Weisheit, Kamba F. Pakoyo. Therapeutic potentials of Vachellia nilotica (L.) extracts in Hepatitis C infection: A reviewScientific African 2021; 13: e00918 doi: 10.1016/j.sciaf.2021.e00918
14
Д. Г. Мальдов, В.Л. Андронова, С.С. Григорян, Е.И. Исаева, П.Г. Дерябин, Д. В. Мишин, А. А. Балакина, А.В. Ильичев, А.А. Терентьев, Г.А. Галегов. РАЗЛИЧИЯ ДЕЙСТВИЯ ИММУНОСТИМУЛИРУЮЩЕГО ПРЕПАРАТА СТИМФОРТЕ ПРИ ИНФЕКЦИЯХ ВИРУСА ГЕПАТИТА C И ВИРУСА ПРОСТОГО ГЕРПЕСА ТИПА 1, "Доклады Академии наук"Доклады Академии Наук 2017; (2): 257 doi: 10.7868/S0869565217320251
15
Pan Hu, Jochen Wilhelm, Gesche Gerresheim, Lyudmila Shalamova, Michael Niepmann. Lnc-ITM2C-1 and GPR55 Are Proviral Host Factors for Hepatitis C VirusViruses 2019; 11(6): 549 doi: 10.3390/v11060549
16
Hossein Ghaderi-Zefrehi, Mohammad Gholami-Fesharaki, Amir Ghorbanzadeh, Farzin Sadeghi. Association of HLA Class II Alleles with Outcome of Hepatitis C Virus Infection: A Systematic Review and Meta-analysisHepatitis Monthly 2021; 21(7) doi: 10.5812/hepatmon.109493
17
Jennifer S. Husson, Bharath Ravichandran, Srijana Jonchhe, Shyamasundaran Kottilil, Eleanor Wilson. Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 InfectionTransplantation Direct 2017; 3(12): e229 doi: 10.1097/TXD.0000000000000744
18
D. G. Maldov, V. L. Andronova, S. S. Grigorian, E. I. Isaeva, P. G. Deryabin, D. V. Mishin, A. A. Balakina, A. V. Ilyichev, A. A. Terentyev, G. A. Galegov. Different effects of the immunostimulatory drug Stimforte on infections of hepatitis C virus and herpes simplex virus type 1Doklady Biological Sciences 2017; 477(1): 219 doi: 10.1134/S0012496617060035
19
Tung Huynh, Johnathan Zhang, Ke-Qin Hu. Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase NormalizationJournal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00014